Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (21) Daniel, Peter Prof. Dr. (1) Jarosch, Ernst Dr. (5) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Quensel, Christina Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Sommer, Thomas Prof. Dr. (14) Willimsky, Gerald Dr. (3) (-) Kammertöns, Thomas Dr. (5) (-) Nguyen, Tam Hoai Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (5) 1998 (1) 1999 (1) 2000 (3) 2001 (1) 2002 (2) 2003 (5) (-) 2004 (6) 2005 (6) 2006 (1) 2007 (2) (-) 2008 (1) 2009 (3) 2010 (2) (-) 2011 (3) 2012 (3) 2013 (4) (-) 2014 (1) 2015 (3) 2016 (2) 2017 (1) 2018 (2) 2019 (2) 2020 (3) 2022 (2) 2023 (1) Cellular Neurosciences (2) Epigenetic Regulation and Chromatin Architecture (12) From Cell States to Function (1) (-) Intracellular Proteolysis (1) Molecular Cardiovascular Research (1) (-) Molecular Immunology and Gene Therapy (10) Pancreatic Organoid Research and Disease Modeling (1) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Systems Biology of Gene Regulatory Elements (3) Translational Oncology of Solid Tumors (1) 11 Results: Active Filter: Kammertöns, Thomas Dr.Nguyen, Tam Hoai Dr.Uckert, Wolfgang Prof. Dr.Intracellular ProteolysisMolecular Immunology and Gene Therapy2004200820112014 Sort: Result score Newest to oldest Oldest to newest January 15, 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto January 01, 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein December 13, 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 15, 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
January 01, 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast
July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
December 13, 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein